We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Lipoprotein(a) Concentrations Correlate With LDL-C in Diabetic Children

By LabMedica International staff writers
Posted on 30 Nov 2021
Cardiovascular disease (CVD) is a significant cause of mortality in those with diabetes. More...
Increased apolipoprotein B (apoB) and low-density lipoprotein cholesterol (LDL-C) have been shown in pediatric patients with diabetes with worsening glycemic control.

Lipoprotein(a) (Lp(a)) is a highly atherogenic lipoprotein that attaches to the apoB 100 moiety of LDL-C particles. Lp(a) is concentration is generally fully expressed by the second year in childhood. Lp(a) is highly heritable, with great concordance between parental levels.

Pediatric Endocrinologists at the University of Alabama School of Medicine (Birmingham, AL, USA) investigate the relationships between serum concentrations of Lp(a) with low-density lipoprotein cholesterol (LDL-C), race, body mass index (BMI), and HbA1c in children with diabetes. Their secondary aim was to evaluate the factors associated with elevated Lp(a) levels. The carried out across-sectional retrospective chart review of pediatric patients, ages 12-19 years, including 607 type 1 diabetes (T1D) and 93 type 2 diabetes (T2D); 49% were male, mean age was 13.2 ± 3.08 years, and the median Lp(a) was 8.00 mg/dL. In addition to standard lipid profile testing, the clinical laboratory also offered Vertical Auto Profile (VAP) testing through a commercial laboratory (Atherotech, Birmingham, AL, USA).

The investigators reported that the Black children had an increased relative risk (RR) of higher Lp(a) compared with White ones (RR 1.25). The median Lp(a) was significantly higher in Black people than in White people, 9 (6-14) versus 7 (5-11). Among patients with T1D, Black people had an increased relative risk of higher Lp(a) than White people (RR 1.23). In T2D, Black participants have 43% higher risk of having elevated Lp(a) than White participants (RR 1.43). In T1D, a 5 mg/dL increase in LDL-C results in 2% increase in Lp(a). In T2D, a 5 mg/dL increase of LDL-C results in an increase of Lp(a) by 3%. LDL-C and BMI are independently associated with Lp(a) (RR = 1.02 and RR = 0.98), respectively. Interestingly, patients with T1D had higher mean levels of Lp(a) despite having a lower BMI compared to children with T2D. Patients with T1D had higher mean HbA1c than those with T2D (9.14% [5.88-12.4] versus 8.27% [5.67-10.87]).

The authors concluded that Lp(a) is strongly associated with LDL-C in children with diabetes, indicating a reduction of LDL-C may additionally reduce cardiovascular risk by lowering Lp(a) levels. Black children with diabetes have a significant burden of Lp(a) concentrations compared with White children. It may be important to consider Lp(a) screening in children with diabetes for disease risk management and implement stricter therapeutic goals for LDL-C reduction. The study was published in the November, 2021 issue of Journal of the Endocrine Society.

Related Links:
University of Alabama School of Medicine
Atherotech



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.